Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Brodalumab in the Modulation of Gut Microbiome in Psoriatic Patient - BOMOGUMIP

NCT04680624 is registered in ClinicalTrials.gov with Association pour la Recherche Clinique et Immunologique as lead sponsor.

NCT NCT04680624
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04680624 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Brodalumab in the Modulation of Gut Microbiome in Psoriatic Patient - BOMOGUMIP
Lead sponsor
Association pour la Recherche Clinique et Immunologique
Phase
Not applicable
Overall status
Unknown status
Start date
January 31, 2021
Completion date
January 31, 2022
Enrollment
15 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis